Detailed Information

Cited 2 time in webofscience Cited 3 time in scopus
Metadata Downloads

Phase II study to investigate the efficacy of trastuzumab biosimilar (Herzuma (R)) plus treatment of physician's choice (TPC) in patients with heavily pretreated HER-2+metastatic breast cancer (KCSG BR 18-14/KM10B)

Full metadata record
DC FieldValueLanguage
dc.contributor.authorSim, Sung Hoon-
dc.contributor.authorKim, Jeong Eun-
dc.contributor.authorKim, Min Hwan-
dc.contributor.authorPark, Yeon Hee-
dc.contributor.authorKim, Jee Hyun-
dc.contributor.authorSuh, Koung Jin-
dc.contributor.authorKoh, Su-Jin-
dc.contributor.authorPark, Kyong Hwa-
dc.contributor.authorKang, Myoung Joo-
dc.contributor.authorAhn, Mi Sun-
dc.contributor.authorLee, Kyoung Eun-
dc.contributor.authorKim, Hee-Jun-
dc.contributor.authorAhn, Hee Kyung-
dc.contributor.authorKim, Han Jo-
dc.contributor.authorPark, Keon Uk-
dc.contributor.authorByun, Jae Ho-
dc.contributor.authorPark, Jin Hyun-
dc.contributor.authorLee, Gyeong-Won-
dc.contributor.authorLee, Keun Seok-
dc.contributor.authorSohn, Joohyuk-
dc.contributor.authorJung, Kyung Hae-
dc.contributor.authorPark, In Hae-
dc.date.accessioned2022-09-26T02:40:12Z-
dc.date.available2022-09-26T02:40:12Z-
dc.date.issued2022-10-
dc.identifier.issn0960-9776-
dc.identifier.issn1532-3080-
dc.identifier.urihttps://scholarworks.korea.ac.kr/kumedicine/handle/2021.sw.kumedicine/61503-
dc.description.abstractWe investigated the efficacy and safety of a trastuzumab biosimilar, Herzuma (R), in combination with treatment of physician's choice (TPC) in patients with HER2+ metastatic breast cancer (MBC) who had failed at least two HER2 directed chemotherapies.-
dc.format.extent7-
dc.language영어-
dc.language.isoENG-
dc.publisherChurchill Livingstone-
dc.titlePhase II study to investigate the efficacy of trastuzumab biosimilar (Herzuma (R)) plus treatment of physician's choice (TPC) in patients with heavily pretreated HER-2+metastatic breast cancer (KCSG BR 18-14/KM10B)-
dc.typeArticle-
dc.publisher.location스코트랜드-
dc.identifier.doi10.1016/j.breast.2022.08.002-
dc.identifier.scopusid2-s2.0-85136302494-
dc.identifier.wosid000854087700004-
dc.identifier.bibliographicCitationBreast, v.65, pp 172 - 178-
dc.citation.titleBreast-
dc.citation.volume65-
dc.citation.startPage172-
dc.citation.endPage178-
dc.type.docTypeArticle-
dc.description.isOpenAccessY-
dc.description.journalRegisteredClassscie-
dc.description.journalRegisteredClassscopus-
dc.relation.journalResearchAreaOncology-
dc.relation.journalResearchAreaObstetrics & Gynecology-
dc.relation.journalWebOfScienceCategoryOncology-
dc.relation.journalWebOfScienceCategoryObstetrics & Gynecology-
dc.subject.keywordPlusDOUBLE-BLIND-
dc.subject.keywordPlusPROGRESSION-
dc.subject.keywordPlusRETREATMENT-
dc.subject.keywordPlusGUIDELINE-
dc.subject.keywordPlusMUTATIONS-
dc.subject.keywordPlusEMTANSINE-
dc.subject.keywordPlusLAPATINIB-
dc.subject.keywordPlusHER2-
dc.subject.keywordAuthorHER2 positive-
dc.subject.keywordAuthorMetastatic breast cancer-
dc.subject.keywordAuthorTrastuzumab biosimilar-
dc.subject.keywordAuthorClinical trial-
dc.subject.keywordAuthorctDNA-
Files in This Item
There are no files associated with this item.
Appears in
Collections
2. Clinical Science > Department of Medical Oncology and Hematology > 1. Journal Articles

qrcode

Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.

Related Researcher

Researcher Park, In Hae photo

Park, In Hae
Guro Hospital (Department of Medical Oncology and Hematology, Guro Hospital)
Read more

Altmetrics

Total Views & Downloads

BROWSE